Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/DRKS00032606
DRKS00032606RecruitingNot Applicable

A cross-sectional study on HPV vaccination in German women undergoing excisional CIN therapy and the impact of reimbursement on the acceptance (HPV vacCINe study) - HPV vacCINe study

MSD Sharp & Dohme GmbH0 sites1,023 target enrollmentStarted: October 2, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
1,023
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
Female

Inclusion Criteria

  • •Subject is scheduled for excisional therapy of CIN
  • •Permanent coverage by a German statutory or private health insurance since at least one year
  • •Signed informed consent form (ICF) including data protection consent and signed contact information sheet

Exclusion Criteria

  • •Subject is not able to read and understand the questionnaires and other study documents (ICF etc.) in German or English language
  • •Subject is pregnant during the enrollment period
  • •Subject is not willing to provide contact information
  • •Subject does not have technical means to complete an electronic questionnaire

Investigators

Similar Trials

Recruiting
Phase 3
Evaluation of the effect of quaternary HPV vaccine in the treatment of women with cervical intraepithelial neoplasia cin1Evaluation of the effect of quaternary HPV vaccine in the treatment of women with cervical intraepithelial neoplasia cin1 of Fatemiye Hospitan, Hamadan.
IRCT20230522058253N2Hamedan University of Medical Sciences300
Recruiting
Phase 3
VAC-WARTS
2024-513671-40-00Assistance Publique Hopitaux De Paris146
Recruiting
Not Applicable
Study of the efficacy of HPV vaccination against cervical cancerCervical cancer
JPRN-UMIN000026769Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Science8,000
Active, not recruiting
Phase 1
VAC-WARTSHPV vaccine
CTIS2024-513671-40-00Assistance Publique Hopitaux De Paris146
Active, not recruiting
Phase 1
VulVaccin studyVulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)
CTIS2023-506792-94-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)498